CDH1 and prostate carcinoma: Several studies have long established that the loss of the homotypic E-cadherin binding machinery correlates with an invasive phenotype in prostate carcinomas (Behrens et al, 1989; Vleminckx et al, 1991; Bussemakers et al, 1992).